- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01789450
Nipple-Areola Complex Sensitivity After the Section of Periareolar Dermis in Breast Reduction
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Preservation of the dermis after decortication regions of the areola and periareolar is considered relevant by most plastic surgeons.
In patients whose CAP should be mobilized through large distances in order to correct breast ptosis, or in cases of dense breasts where noted little slip of skin over the breast parenchyma, the periareolar dermis causes limitation on the mobility of the NAC.
In clinical practice, there is a greater mobilization of NAC when making a careful section of the dermis after decortication. In contrast, the appearance of partial necrosis in these cases has become a rarity, as no case of total necrosis was observed.
Given the technical benefit observed due to greater mobilization, there is no report in the literature about how behaves the sensitivity of the NAC in these cases.
To evaluate the sensitivity of the NAC will be used Semmes-Weisnstein's monofilament. Each point will be obtained five measurements. The largest will be scorned and the lowest value. The final value of each point corresponds to an arithmetic mean of the three remaining values.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jairo Z Sá, surgeon
- Phone Number: +55 81 34675717
- Email: jairozacche@gmail.com
Study Locations
-
-
Pernambuco
-
Recife, Pernambuco, Brazil, 50670-607
- Hospital das Clínicas da UFPE
-
Contact:
- Jairo Z Sá, surgeon
- Phone Number: +55 81 34675717
- Email: jairozacche@gmail.com
-
Principal Investigator:
- Jairo Z Sá, surgeon
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients who willingly seek the service requesting breast reduction or mastopexy;
- Patients who after consultation with the surgeon who led the research presents realistic expectation, being safe with the possible outcome of the surgery;
- Patients who undertake to comply with the protocol previously presented and discussed with them;
Exclusion Criteria:
- Patients with prior breast surgery;
- Patients with body mass index (BMI) greater than 34.9;
- Patients with severe anemia;
- Patients with neurological disease;
- Patients with impairment cardiovascular;
- Metabolic diseases - diabetes;
- Patients with autoimmune disease;
- Menopausal patients
- Patients with collagen disease;
- Patients with psychiatric disorders.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Section of Periareolar Dermis
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Nipple-Areola Complex (NAC) Sensitivity
Time Frame: 3 weeks
|
To evaluate the sensitivity of the NAC in breast reduction
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Nipple-Areola Complex (NAC) sensitivity
Time Frame: 6 weeks
|
To evaluate the sensitivity of the NAC in breast reduction
|
6 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Nipple-Areola Complex sensitivity
Time Frame: 12 months
|
To evaluate the sensitivity of the NAC in breast reduction
|
12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jairo Z Sá, surgeon, Hospital das Clínicas da Universidade Federal de Pernambuco
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UFPE (CAAE N. 79139717.6.0000.5208)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sensitivity of Nipple-areolar Complex
-
FixNip LtdCompletedReconstruction of the Breast Nipple and Areola ComplexIsrael
-
Foundation for Maternal Infant and Lactation KnowledgeCompletedTo Collect Measurements of the Nipple | To Record Clinical Observations of the Nipple, Areola, and Breast Tissue Before and After Breastfeeding | To Record Clinical Observations of the Nipple, Areola, and Breast Tissue Before and After Expressing Milk With 3 Different Electric Breast...United States
-
Duke UniversityBracco Diagnostics, IncTerminatedBreast Neoplasms | Disorder of NippleUnited States
-
University of DelawareRecruitingSalt Sensitivity of Blood PressureUnited States
-
University of LeedsUnknownPostoperative Sensitivity of Existing Dental Filling MaterialsUnited Kingdom
-
Cairo UniversityNot yet recruitingBleaching Effect and Postoperative Sensitivity of Strawberry Extract
-
The Danish Research Centre for Chemical SensitivitiesAage Bangs FondCompletedMultiple Chemical SensitivityDenmark
-
The Danish Research Centre for Chemical SensitivitiesCompletedMultiple Chemical SensitivityDenmark
-
Galderma R&DCompletedDetermine Sensitivity of Skin to Cetaphil Daily Advance Ultra Hydrating Lotion
-
Stefania CostiArcispedale Santa Maria Nuova-IRCCSCompletedComplex Patients: Patients With High Level of Complexity Regardless of the Pathology of Origin
Clinical Trials on Section of Periareolar Dermis in Breast Reduction.
-
Dr.Jhuma BiswasCompletedCesarean Wound Disruption | Cesarean Section; InfectionIndia
-
Roswell Park Cancer InstituteCompletedStage IV Breast CancerUnited States
-
A.O. Ospedale Papa Giovanni XXIIIUnknownIncisional HerniaItaly
-
Yale UniversityCompletedBreast Cancer | Chemotherapy Induced Peripheral Neuropathy | Paclitaxel Induced NeuropathyUnited States
-
Groupe Hospitalier Nord-EssonneRecruitingBreast ReductionFrance
-
Alexandria UniversityCompleted
-
University of PennsylvaniaPfizer; Pennsylvania Department of Health; Dickinson CollegeCompleted
-
The Netherlands Cancer InstituteUnknownMyxoid Liposarcoma of Soft TissueNetherlands, United Kingdom, Norway, United States, Denmark
-
Instituto Brasileiro de Controle do CancerRecruiting
-
Centers for Disease Control and PreventionWashington University School of Medicine; The Miriam Hospital; Hennepin Healthcare... and other collaboratorsCompletedHIV Infections | Sexually Transmitted DiseasesUnited States